NCT02913495View on ClinicalTrials.gov

Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth

PHASE4CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

August 31, 2021

Study Completion Date

September 30, 2021

Conditions
Premature Birth
Interventions
DRUG

Vaginal Progesterone

DRUG

Intramuscular Progesterone (17 alpha hydroxprogesterone caproate)

Trial Locations (3)

19107

Thomas Jefferson University Hospital, Philadelphia

Unknown

George Washington University, Washington D.C.

01199

Baystate Medical Center, Springfield

All Listed Sponsors
collaborator

Baystate Medical Center

OTHER

collaborator

George Washington University

OTHER

collaborator

Vriginia Commonwealth University

UNKNOWN

collaborator

Ohio State University

OTHER

lead

Thomas Jefferson University

OTHER

NCT02913495 - Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth | Biotech Hunter | Biotech Hunter